These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16917239)

  • 1. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.
    Mishkin DS; Van Deinse W; Becker JM; Farraye FA
    Inflamm Bowel Dis; 2006 Aug; 12(8):827-8. PubMed ID: 16917239
    [No Abstract]   [Full Text] [Related]  

  • 2. The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.
    Coburn LA; Wise PE; Schwartz DA
    Dig Dis Sci; 2006 Nov; 51(11):2045-7. PubMed ID: 17009112
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.
    Jürgens M; Brand S; Filik L; Hübener C; Hasbargen U; Beigel F; Tillack C; Göke B; Ochsenkühn T; Seiderer J
    Inflamm Bowel Dis; 2010 Oct; 16(10):1634-6. PubMed ID: 20027647
    [No Abstract]   [Full Text] [Related]  

  • 4. Adalimumab use in pregnancy.
    Vesga L; Terdiman JP; Mahadevan U
    Gut; 2005 Jun; 54(6):890. PubMed ID: 15888806
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?
    van Deventer SJ
    Gut; 2002 Sep; 51(3):362-3. PubMed ID: 12171957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J; Kucharzik T
    Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Term pregnancy in a patient with Crohn's disease under treatment with adalimumab].
    Sánchez Muñoz D; Hoyas Pablos E; Ramírez Martín Del Campo M; Núñez Hospital D; Guerrero Jiménez P
    Gastroenterol Hepatol; 2005; 28(7):435. PubMed ID: 16137481
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease.
    Loftus EV; Johnson SJ; Yu AP; Wu EQ; Chao J; Mulani PM
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1302-9. PubMed ID: 19465858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review.
    Da W; Zhu J; Wang L; Lu Y
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):885-91. PubMed ID: 23817447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract]   [Full Text] [Related]  

  • 11. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.
    Mahadevan U; Cucchiara S; Hyams JS; Steinwurz F; Nuti F; Travis SP; Sandborn WJ; Colombel JF
    Am J Gastroenterol; 2011 Feb; 106(2):214-23; quiz 224. PubMed ID: 21157441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANTS extension study: how best to use anti-TNF drugs in Crohn's disease.
    Parkes GC; Hedin CRH
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):489-491. PubMed ID: 38640938
    [No Abstract]   [Full Text] [Related]  

  • 13. [What can be expected from biological therapies for Crohn's disease?].
    Lemann M
    Gastroenterol Clin Biol; 2001 Nov; 25(11):945-7. PubMed ID: 11845043
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 15. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
    Angelucci E; Cocco A; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2008 Mar; 14(3):435-6. PubMed ID: 18050300
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab, a novel anti-tumor necrosis factor-alpha antibody in a child with refractory Crohn's disease.
    Mian S; Baron H
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):357-9. PubMed ID: 16131995
    [No Abstract]   [Full Text] [Related]  

  • 17. Adalimumab for cutaneous metastatic Crohn's disease.
    Cury DB; Moss AC; Elias G; Nakao A
    Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab treatment and pregnancy outcome in active Crohn's disease.
    Srinivasan R
    Am J Gastroenterol; 2001 Jul; 96(7):2274-5. PubMed ID: 11467677
    [No Abstract]   [Full Text] [Related]  

  • 19. Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab.
    Tursi A
    Acta Gastroenterol Belg; 2013 Jun; 76(2):264-5. PubMed ID: 23898572
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.